Endothelial Nitric Oxide Synthase Mediates Lymphangiogenesis and Lymphatic Metastasis
- 1 April 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (7), 2801-2808
- https://doi.org/10.1158/0008-5472.can-08-4051
Abstract
Lymphatic metastasis is a critical determinant of cancer prognosis. Recently, several lymphangiogenic molecules such as vascular endothelial growth factor (VEGF)-C and VEGF-D were identified. However, the mechanistic understanding of lymphatic metastasis is still in infancy. Nitric oxide (NO) plays a crucial role in regulating blood vessel growth and function as well as lymphatic vessel function. NO synthase (NOS) expression correlates with lymphatic metastasis. However, causal relationship between NOS and lymphatic metastasis has not been documented. To this end, we first show that both VEGF receptor-2 and VEGF receptor-3 stimulation activate eNOS in lymphatic endothelial cells and that NO donors induce proliferation and/or survival of cultured lymphatic endothelial cells in a dose-dependent manner. We find that an NOS inhibitor, L-NMMA, blocked regeneration of lymphatic vessels. Using intravital microscopy that allows us to visualize the steps of lymphatic metastasis, we show that genetic deletion of eNOS as well as NOS blockade attenuates peritumor lymphatic hyperplasia of VEGF-C–overexpressing T241 fibrosarcomas and decreases the delivery of metastatic tumor cells to the draining lymph nodes. Genetic deletion of eNOS in the host also leads to a decrease in T241 tumor cell dissemination to the lymph nodes and macroscopic lymph node metastasis of B16F10 melanoma. These findings indicate that eNOS mediates VEGF-C–induced lymphangiogenesis and, consequently, plays a critical role in lymphatic metastasis. Our findings explain the correlation between NOS and lymphatic metastasis seen in a number of human tumors and open the door for potential therapies exploiting NO signaling to treat diseases of the lymphatic system. [Cancer Res 2009;69(7):2801–8]Other Versions
This publication has 32 references indexed in Scilit:
- Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesisLaboratory Investigation, 2009
- Perivascular nitric oxide gradients normalize tumor vasculatureNature Medicine, 2008
- Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase α1β1‐impact on inflammationThe FASEB Journal, 2007
- eNOS at a glanceJournal of Cell Science, 2004
- Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in miceCancer Cell, 2003
- Interstitial Flow as a Guide for LymphangiogenesisCirculation Research, 2003
- Lymphatic Metastasis in the Absence of Functional Intratumor LymphaticsScience, 2002
- Molecular mechanisms of lymphangiogenesis in health and diseaseCancer Cell, 2002
- Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3The EMBO Journal, 2001
- Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeabilityProceedings of the National Academy of Sciences of the United States of America, 2001